BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Neuromed Pharmaceuticals

Neuromed is a biopharmaceutical company developing new and improved pain therapies. Lead drug candidate, OROS Hydromorphone®, in Phase 3 clinical development, is an extended release formulation of hydromorphone. In collaboration with Merck, Neuromed is also researching compounds designed to block the N-type calcium channel, a target linked to pain signal transmission. Separately, Neuromed is developing T-type calcium channel blockers aimed at treating acute and chronic pain, hypertension and epilepsy. Neuromed has offices in Philadelphia, Pennsylvania and Vancouver, British Columbia.


Contact Details:
301-2389 Health Sciences Mall, UBC
Vancouver
BC
V6T 1Z3
Canada
Tel:604 909 2530
Fax:604 909 2538
Email:info@neuromed.com
WWW:

www.neuromed.com/




Loading...

Recent Publications by Neuromed Pharmaceuticals:

Linking calcium-channel isoforms to potential therapies.
Voltage-gated calcium channels underlie a plethora of physiological...
5th July, 2008
Neuromed Pharmaceuticals, Vancouver, Canada. Curr Opin Investig Drugs. 2008 Jul;9(7):707-15.
Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.
Neuronal nicotinic acetylcholine receptors (nAChRs) have been a target for...
7th November, 2007
Neuromed Pharmaceuticals, Biochem Pharmacol. 2007 Oct 15;74(8):1092-101. Epub 2007 Jun 26.
DOI Direct Link

BioNews Results for Neuromed Pharmaceuticals:

Who's on the List
Pharma Voice:  Jul 27 2008 9:46PM Matching: neuromed pharmaceuticals
Cubist Pharmaceuticals Appoints Mark H.N. Corrigan, M.D., to Its Board of Directors
Pharma Live:  Jun 24 2008 7:52PM Matching: neuromed pharmaceuticals

Neuromed Pharmaceuticals Patents:

US Patent No.Title
7378420 Urea derivatives as calcium channel blockers
7297504 Methods for identifying agonists and antagonists of human T-type calcium channels
7294485 Rat calcium channel subunits and related probes, cell lines and methods
7270949 Fluorescence based T-type channel assay
7244758 N-type calcium channel blockers

View more Neuromed Pharmaceuticals patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 224 times since April 2007, the link to the organisation's website has been followed 50 times

Recent Search Terms used to find this page: neuromed | neuromed technologies | Neuromed V6T 1Z4 Neuromed | .

Search for more companies in Vancouver

Search for more companies in BC



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Neuromed Pharmaceuticals
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.